Skip to main content
SpringerLink
Log in

Adalimumab/infliximab/ustekinumab

Seroconversion of latent tuberculosis infection (LTBI) from negative to positive and pulmonary tuberculosis: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Akdogan N, et al. Serial Quantiferon-TB Gold test results in 279 patients with psoriasis receiving biologic therapy. Dermatologic Therapy 34: No. 1, Jan 2021. Available from: URL: http://doi.org/10.1111/dth.14699

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/infliximab/ustekinumab. Reactions Weekly 1847, 23 (2021). https://doi.org/10.1007/s40278-021-92580-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-92580-1

Search

Navigation